Efficacy and Safety of Three Doses of Vildagliptin in Drug Naive Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the long term safety and effectiveness of three doses
of vildagliptin, an unapproved drug, compared to placebo in lowering overall blood glucose
levels in people with type 2 diabetes who have not previously been treated with drug therapy
to lower their blood sugar.